Navigation Links
Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter and Full Year 2009 Results
Date:2/1/2010

CRANBURY, N.J., Feb. 1 /PRNewswire-FirstCall/ -- Innophos Holdings, Inc. (Nasdaq: IPHS), a leading specialty phosphates producer in North America, today announced that it will host a live conference call on Thursday, February 18, 2010 at 10:00 am ET to discuss its fourth quarter and full year 2009 results.

The press release detailing fourth quarter results will be issued on Wednesday, February 17, 2010 after market close.

The conference call can be accessed by dialing 888-713-4216  (U.S.) or 617-213-4868

(international) and entering passcode 29348676.  A replay will be available between 1:00 pm ET on

February 18 and 1:00 pm ET on February 24, 2010. The replay is accessible by dialing 888-286-8010 (U.S.) or 617-801-6888 (international) and entering passcode 46525811.

If you would like to pre-register for the conference call use the following link:

https://www.theconferencingservice.com/prereg/key.process?key=PYMWC3Y3X

Pre-registering is not mandatory but is recommended, as it will provide you immediate entry into the call and will facilitate the timely start of the conference. You will receive a code that allows you to enter the call directly.  Pre-registration only takes a few moments, and you may do so at any time, including up to and after call start time. To pre-register, please click the link above. Alternately, if you would rather be placed into the call by an operator, please call at least 15 minutes prior to call start time.

Alternately, the webcast of the conference call can be accessed live and as a replay at Innophos' web site www.innophos.com in the Investor Relations Events section.

About Innophos, Inc.

Innophos Holdings, Inc., the holding company for a leading North American manufacturer of specialty phosphates, serves a diverse range of customers across multiple applications, geographies and channels.  Innophos offers a broad suite of products used in a wide variety of food and beverage, consumer products, pharmaceutical and industrial applications.  Innophos' market-leading positions derive from its experience and dedication to customer service and innovation.  Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Port Maitland, ON (Canada); and Coatzacoalcos, Veracruz and Mission Hills, Guanajuato (Mexico). For more information please see www.innophos.com.

SOURCE Innophos Holdings, Inc.

RELATED LINKS
http://www.innophos.com

'/>"/>

SOURCE Innophos Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive
2. D-M-S Holdings, Inc. Announces the Filing of a Lawsuit Against Veridian Healthcare, LLC, Steven M. Bisulca and Michael Mazza
3. Applied Technology Holdings, Inc. Opens New Headquarters in California
4. LifeCare Holdings, Inc. Announces Third Quarter Results
5. Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes
6. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
7. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
8. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast
9. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
10. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
11. Roper Industries Schedules Fourth Quarter 2009 Financial Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... -- CANTEL MEDICAL CORP. (NYSE: CMD ) reported ... diluted share, on a 22.1% increase in sales to a ... This compares with net income of $14,254,000, or $0.34 per ... ended October 31, 2015. Non-GAAP net income ... to $21,323,000, or $0.51 per diluted share, compared with non-GAAP ...
(Date:12/8/2016)... 8, 2016   Mederi Therapeutics Inc . has announced regulatory approval by CFDA ... treatment for chronic gastroesophageal reflux disease (GERD). Continue ... ... the Chinese Congress of Digestive Endoscopy, by Professor Jun Liu, Director of Endoscopy at ... , "We are very pleased that Mederi ...
(Date:12/8/2016)... , and SAN DIEGO , Dec. ... services and solutions with cutting edge next-generation sequencing and bioinformatics ... biotechnology company; and the Genome Institute of Singapore ... – a new joint venture between Novogene and AITbiotech – ... Biopolis, Singapore .   The ...
Breaking Medicine Technology:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... financial consulting services to residential and commercial clients in the northern Alabama and ... for Nobis Works. , Since 1977, Nobis Works has built a network of ...
(Date:12/7/2016)... ... December 07, 2016 , ... Students attending ... the unique opportunity to get hands-on experience in an emergency medical simulation, When ... experience to gain invaluable, real-life medical skills that are critical success in a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Children exposed to secondhand ... at the Icahn School of Medicine at Mount Sinai has found. The study ... young children are exposed to secondhand marijuana smoke, measurable amounts of primary metabolite ...
(Date:12/7/2016)... ... December 07, 2016 , ... OC87 ... with a schizophrenic mother in a unique, personal perspective through animation. , ... trauma and addictive disorders at her private psychotherapy practice. Sheri’s mother, Pearl, lived ...
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any ... useful, properly analyzed data. The team at Beckman Coulter has designed Kaluza, templates with ... speed' and the need to operate in a GLP (Good Laboratory Practice) fashion. , ...
Breaking Medicine News(10 mins):